Miras, Dionne Chixx .

HRN: 16-36-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/27/2022
11/27/2022
IV
450 Mg
Q6
T/C UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractMultiple Infections (tick All Sites)    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: